Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10006324HBVENSG00000160752.15protein_codingFDPSNoNo2224A0A087X090
P14324
TVIS10003145HBVENSG00000160752.15protein_codingFDPSNoNo2224A0A087X090
P14324
TVIS10022102HBVENSG00000160752.15protein_codingFDPSNoNo2224A0A087X090
P14324
TVIS10025984HBVENSG00000160752.15protein_codingFDPSNoNo2224A0A087X090
P14324
TVIS10051965HBVENSG00000160752.15protein_codingFDPSNoNo2224A0A087X090
P14324
TVIS10052093HBVENSG00000160752.15protein_codingFDPSNoNo2224A0A087X090
P14324
TVIS30025272HIVENSG00000160752.15protein_codingFDPSNoNo2224A0A087X090
P14324
TVIS30025273HIVENSG00000160752.15protein_codingFDPSNoNo2224A0A087X090
P14324
TCGA Plot Options
Drug Information
GeneFDPS
DrugBank IDDB00710
Drug NameIbandronate
Target IDBE0000776
UniProt IDP14324
Regulation Typeinhibitor
PubMed IDs11752352; 16932286; 11160603; 16892359
CitationsChen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.@@Chapurlat RD, Delmas PD: Drug insight: Bisphosphonates for postmenopausal osteoporosis. Nat Clin Pract Endocrinol Metab. 2006 Apr;2(4):211-9; quiz following 238.@@Dunford JE, Thompson K, Coxon FP, Luckman SP, Hahn FM, Poulter CD, Ebetino FH, Rogers MJ: Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. J Pharmacol Exp Ther. 2001 Feb;296(2):235-42.@@Rondeau JM, Bitsch F, Bourgier E, Geiser M, Hemmig R, Kroemer M, Lehmann S, Ramage P, Rieffel S, Strauss A, Green JR, Jahnke W: Structural basis for the exceptional in vivo efficacy of bisphosphonate drugs. ChemMedChem. 2006 Feb;1(2):267-73.
GroupsApproved; Investigational
Direct ClassificationBisphosphonates
SMILESCCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O
PathwaysIbandronate Action Pathway
PharmGKBPA10270
ChEMBLCHEMBL997